SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Identix (IDNX)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jean who wrote (12346)2/2/1999 6:13:00 PM
From: David  Read Replies (2) of 26039
 
Where are we now?

Industry: The biometric industry is far further along than it was eighteen months ago. Many more startups, many more pilots and investments in collateral infrastructure by major companies in bio-ID. Prices have been coming down. Progress is being made on a common API. The industry momentum appears to be strengthening. This means there are good long-term prospects here.

Identix overview: This company has the broadest reach -- from AFIS to access control to computer sign-ons -- of any in the marketplace. Its alliances are extremely valuable. The management has maneuvered within the nascent marketplace better than its competitors, and Identix is self-sustaining in revenues.

Identix presently: Has a strong, albeit not exclusive, position in the AFIS field and ANADAC appears increasingly profitable. These two groups provide a stable financial base for investments in bio-ID and potential acquisitions. The Identicator purchase looks better every day, and Compaq is in fact selling product. The F3 line has yet to come through with a big deal in computer networking application. In fact, it has to be rated a disappointment so far. Multiple bio-ID pilots provide potentially big payoffs down the road.

Identix near-term: Identicator purchase must be digested. Further, Identix must use both F3 and IDT technologies to improve each line. I don't believe we'll see large profits in the next quarter or two; even if O'Hare or another pilot hits, profits will come later.

Identix medium-term (six to eighteen months out): Revenues should begin to take off in ANADAC and bio-ID, with both top and bottom lines showing the change. Probability of roll out of some of the ongoing pilots. AFIS market should continue as profitable. I predict an IDX acquisition of a VPN company (probably Internet Dynamics) in order to fill in a gap in the product line. (I think Oracle handles this area in certain F3 applications.) All biometrics should get a boost with the adoption of BioAPI. If someone is going to acquire this company, this is the time frame to worry about -- with an obvious marketplace and accepted products just beginning. IDX could be taken out somewhere just over $30/share. Many newbies appear on the SI board and you don't even want to think about what the Yahoo board would look like.

Identix long term (more than eighteen months out): If Fowler/Pieper perform well, this will be a hot stock, with revenues rising by 100% to 200% a year, good profits, and a very high multiple. Revenues could jump even higher if Mastercard buys 50 million scanners from Identix. (My dream scenario.) At this point, takeover fears should recede.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext